ProteinQure named one of CB Insights' Game Changers for 2020

Ontario Industry Updates
Written By Guest User
ProteinQure+logo.jpg

ProteinQure, a Toronto-based biotech which has designed a platform to automate the computational design of protein-based drugs, has been named one of CB Insights’ Game Changers for 2020. CB Insights is a venture capital and private company database used by investors and startups.

Guest User
Previous

Deep Genomics raises $40 million in Series B round
Next

Synaptive Medical Announces Close of $25M Preferred Share Financing